Success Story: NIW Approved For An Iranian PhD Student Without Any RFE Issues
Client’s Testimonial:
“Thank you for all your excellent work and for sharing the great news.”
On February 4th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Student in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: PhD Student
Country of Origin: Iran
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: February 4th, 2025
Processing Time: 5 months, 16 days
Case Summary:
When the Client first set out on the path of biomedical engineering, his vision was clear: to harness the power of stem cell technology and material science to create solutions for some of the most urgent medical challenges of our time. With an M.S. in medical biotechnology, the Client has focused his career on engineering accurate multicellular systems and novel therapies designed to address the shortage of human organs for transplant, provide better models for drug discovery, and design advanced delivery systems to treat diseases such as cardiovascular disease, chronic kidney disease, and cancer.
This endeavor is not only scientifically ambitious but also of profound national importance. By creating accurate biological models and developing innovative therapeutic platforms, the Client’s research holds the potential to transform healthcare delivery in the United States, saving lives while reducing costs and improving patient outcomes.
Over the course of his career, the Client has authored 6 peer-reviewed journal articles, including 1 first-authored and 2 co-first-authored papers, with an additional article already accepted for publication. His work has been cited 719 times according to Google Scholar, a clear measure of its influence and utility across the global biomedical research community. Beyond publications, he has also been entrusted with at least 3 peer review assignments, a mark of professional recognition that underscores his authority in evaluating cutting-edge science.
Importantly, the strength of his case was bolstered by 2 recommendation letters from established experts in the field, each attesting to the originality, significance, and translational potential of his work.
“[Client’s] skillset is irreplaceable, given its immense benefits to stem cell research, healthcare, and medical advancement. It is imperative that he be allowed to carry out his research uninterrupted so that the United States is able to benefit fully from its value.”
Despite the rigorous scrutiny of the NIW process, USCIS recognized that the Client’s proposed endeavor carries substantial merit and national importance, and that he is well-positioned to advance this critical work.
The approval of his I-140 NIW petition affirms not only the Client’s track record of impactful contributions but also his potential to continue driving innovation in regenerative medicine, therapeutic development, and organ transplantation research. This milestone also reflects our firm’s commitment to guiding talented researchers through the complexities of the NIW process and ensuring their expertise is recognized at the national level.